A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
NCT 05914116 Brief Summary This is a dose-escalation and dose-expansion Phase 1/2a…
Read more arrow_forwardNCT 05914116 Brief Summary This is a dose-escalation and dose-expansion Phase 1/2a…
Read more arrow_forwardACTRN 12624001138572 Brief Summary This study aims to determine the safety, tolerability…
Read more arrow_forwardNCT 05304377 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12622000993796 Brief Summary AXA-042 functions through a multi-cellular mechanism to re-engage…
Read more arrow_forwardACTRN 12623001072606 Brief Summary This study aims to assess the effect of…
Read more arrow_forwardNCT 04973605 Brief Summary Study consists of two parts, a part 1…
Read more arrow_forwardNCT 04482309 Brief Summary This is an open-label, multi-center, multi-cohort, Phase 2…
Read more arrow_forwardACTRN 12619000746134 Brief Summary The purpose of this study is to determine…
Read more arrow_forwardNCT 06514794 Brief Summary The main purpose of this study is to…
Read more arrow_forwardACTRN 12621001347853 Brief Summary This study will assess the anti-cancer activity of…
Read more arrow_forward